Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.
R O Brady, … , R M Bradley, D Shapiro
R O Brady, … , R M Bradley, D Shapiro
Published July 1, 1966
Citation Information: J Clin Invest. 1966;45(7):1112-1115. https://doi.org/10.1172/JCI105417.
View: Text | PDF
Research Article Article has an altmetric score of 6

Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.

  • Text
  • PDF
Abstract

Authors

R O Brady, J N Kanfer, R M Bradley, D Shapiro

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2001 2000 1999 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 1973 1972 1971 1970 1969 1968 1967 1966 1960 Total
Citations: 3 4 4 6 6 9 19 17 9 3 13 5 8 6 11 12 4 2 7 10 7 4 7 3 1 3 3 1 1 3 4 1 4 1 1 3 1 2 4 3 3 1 3 2 5 8 3 8 9 8 9 7 10 7 7 3 1 1 310
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2017 (9)

Title and authors Publication Year
Roscoe O. Brady: Physician whose pioneering discoveries in lipid biochemistry revolutionized treatment and understanding of lysosomal diseases
JM Aerts, TM Cox
Blood Cells, Molecules, and Diseases 2017
Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes
WW Kallemeijn, S Scheij, S Hoogendoorn, MD Witte, DH Chao, CP van Roomen, R Ottenhoff, HS Overkleeft, RG Boot, JM Aerts, A Dardis
PloS one 2017
Altered Differentiation Potential of Gaucher’s Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation
O Awad, LM Panicker, RM Deranieh, MP Srikanth, RA Brown, A Voit, T Peesay, TS Park, ET Zambidis, RA Feldman
Stem Cell Reports 2017
Stabilization of Glucocerebrosidase by Active Site Occupancy
FB Bdira, WW Kallemeijn, SV Oussoren, S Scheij, B Bleijlevens, BI Florea, CP van Roomen, R Ottenhoff, MJ van Kooten, MT Walvoort, MD Witte, RG Boot, M Ubbink, HS Overkleeft, JM Aerts
ACS chemical biology 2017
Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy
CI Ha, S DeArmey, H Cope, M Rairikar, PS Kishnani
Molecular Genetics and Metabolism Reports 2017
Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems
K Okamoto, T Nakashima, M Shinohara, T Negishi-Koga, N Komatsu, A Terashima, S Sawa, T Nitta, H Takayanagi
Physiological reviews 2017
The metabolism of glucocerebrosides — From 1965 to the present
AH Futerman, FM Platt
Molecular Genetics and Metabolism 2017
Enrichment of apoplastic fluid with therapeutic recombinant protein for efficient biofarming
A Chatterjee, NC Das, S Raha, IB Maiti, A Shrestha, A Khan, S Acharya, N Dey
Biotechnology Progress 2017
Long-term response in biochemical markers of bone turnover during enzyme replacement therapy in a case-series of patients with Gaucher disease type I from Northern Greece
E Vargiami, M Dimitriadou, M Economou, A Christoforidis, D I Zafeiriou
Hippokratia 2017

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
106 readers on Mendeley
See more details